直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Use of the Term “Including” in Description of Disputed Term Cannot Override Remainder of the Intrinsic Record

May 1, 2023

Authored and Edited by Sneha Nyshadham; Caitlin E. Fowler; Elizabeth D. Ferrill

In Sequoia Technology, LLC v. Dell, Inc., No. 2021-2263 (Fed. Cir. April 12, 2023), the Federal Circuit reversed a District of Delaware finding certain claims of U.S. Patent No. 6,718,436 ineligible under 35 U.S.C. § 101 while affirming the district court’s finding of non-infringement.

Sequoia sued several defendants for infringement of the ’436 patent, which is directed to “a method for managing a logical volume for minimizing a size of metadata and supporting dynamic online resizing” and “a computer-readable recording medium storing a program or data structure for embodying the method.”  During claim construction, the court was tasked with construing several phrases, including “computer-readable recording medium,” which the court construed to include transitory media. In light of the district court’s claim construction, the parties stipulated that claims 8-10 are ineligible under 35 U.S.C. § 101.

On appeal, the Federal Circuit found the district court erred in its construction of “computer-readable recording medium.” The Court explained that the language of the claims and the specification demonstrate that the claims are not directed to a transitory media, but rather, only to a non-transient storage medium.  In doing so, the court rejected the appellee’s reliance on the use of the term “including” to argue that the description in the specification is open-ended and could include transitory media. The Court explained that

the use of a term denoting a non-exhaustive list does not override the requirement that claims be construed in the context of the entire patent. Finally, the Court found that the district court erred in relying on extrinsic expert evidence that was inconsistent with the intrinsic evidence. Thus, the Court reversed the district court’s judgment that claims 8-10 are ineligible under 35 U.S.C. § 101.

Tags

validity, claim construction, 35 U.S.C. § 101

Related Practices

Appeals, Issues, and Legal Strategy

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Related Industries

AI, Electronics, and Information Technology

Electrical and Computer Technology

Contacts

Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

IAM Live: Navigating the UPC 2026

November 4, 2026

Paris

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Hybrid Conference

Intellectual Property Law Institute 2026 – California

October 19-20, 2026

San Francisco

Hybrid Conference

Intellectual Property Law Institute 2026 – New York

September 28-29, 2026

New York

Conference

Finnegan IP Summit 2026: Celebrating an Inclusive Talent Pipeline

August 11-13, 2026

Washington, DC

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

Webinar

Webinar

Early Motions in Trade Secret Litigation – Offensive and Defensive Insights

July 15, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP